Literature DB >> 29330120

An update on the role of nanovehicles in nose-to-brain drug delivery.

Yunhai Feng1, Haisheng He2, Fengqian Li1, Yi Lu2, Jianping Qi2, Wei Wu3.   

Abstract

A quantitative analysis has cast doubt over the limited advantages provided by particles for nose-to-brain (NTB) drug delivery. Thus, it is imperative to identify the role of nanovehicles in NTB drug delivery. If nanocarriers are used merely as an option to improve various properties of the drugs or the formulations, it is difficult for them to outperform conventional formulations, such as solutions or gels. However, nanovehicles bring about special features, such as maintenance of the solubilized state of drugs, sustained or delayed release, and enhanced penetration because of surface modifications, all of which lead to enhanced NTB delivery efficiency.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29330120     DOI: 10.1016/j.drudis.2018.01.005

Source DB:  PubMed          Journal:  Drug Discov Today        ISSN: 1359-6446            Impact factor:   7.851


  18 in total

1.  Superiority of TPGS-loaded micelles in the brain delivery of vinpocetine via administration of thermosensitive intranasal gel.

Authors:  Tarek A Ahmed; Khalid M El-Say; Osama Aa Ahmed; Bader M Aljaeid
Journal:  Int J Nanomedicine       Date:  2019-07-23

2.  Donepezil HCl Liposomes: Development, Characterization, Cytotoxicity, and Pharmacokinetic Study.

Authors:  Amarjitsing Rajput; Shital Butani
Journal:  AAPS PharmSciTech       Date:  2022-02-11       Impact factor: 3.246

Review 3.  Lipid-Based Nanocarriers via Nose-to-Brain Pathway for Central Nervous System Disorders.

Authors:  Thuy Trang Nguyen; Thi Thuy Dung Nguyen; Nguyen-Minh-An Tran; Giau Van Vo
Journal:  Neurochem Res       Date:  2021-11-20       Impact factor: 3.996

4.  Impact of particle size and pH on protein corona formation of solid lipid nanoparticles: A proof-of-concept study.

Authors:  Wenhao Wang; Zhengwei Huang; Yanbei Li; Wenhua Wang; Jiayu Shi; Fangqin Fu; Ying Huang; Xin Pan; Chuanbin Wu
Journal:  Acta Pharm Sin B       Date:  2020-10-29       Impact factor: 11.413

Review 5.  New Opportunity to Formulate Intranasal Vaccines and Drug Delivery Systems Based on Chitosan.

Authors:  Roxana Popescu; Mihaela Violeta Ghica; Cristina-Elena Dinu-Pîrvu; Valentina Anuța; Dumitru Lupuliasa; Lăcrămioara Popa
Journal:  Int J Mol Sci       Date:  2020-07-16       Impact factor: 5.923

6.  Formulation Strategies to Improve Nose-to-Brain Delivery of Donepezil.

Authors:  Lupe Carolina Espinoza; Marcelle Silva-Abreu; Beatriz Clares; María José Rodríguez-Lagunas; Lyda Halbaut; María-Alexandra Cañas; Ana Cristina Calpena
Journal:  Pharmaceutics       Date:  2019-02-01       Impact factor: 6.321

7.  RVG29-modified microRNA-loaded nanoparticles improve ischemic brain injury by nasal delivery.

Authors:  Rubin Hao; Bixi Sun; Lihua Yang; Chun Ma; Shuling Li
Journal:  Drug Deliv       Date:  2020-12       Impact factor: 6.419

Review 8.  Surface-Modified Nanocarriers for Nose-to-Brain Delivery: From Bioadhesion to Targeting.

Authors:  Fabio Sonvico; Adryana Clementino; Francesca Buttini; Gaia Colombo; Silvia Pescina; Silvia Stanisçuaski Guterres; Adriana Raffin Pohlmann; Sara Nicoli
Journal:  Pharmaceutics       Date:  2018-03-15       Impact factor: 6.321

Review 9.  Liposomal Formulations for Nose-to-Brain Delivery: Recent Advances and Future Perspectives.

Authors:  Soon-Seok Hong; Kyung Taek Oh; Han-Gon Choi; Soo-Jeong Lim
Journal:  Pharmaceutics       Date:  2019-10-17       Impact factor: 6.321

10.  Mixed Amphiphilic Polymeric Nanoparticles of Chitosan, Poly(vinyl alcohol) and Poly(methyl methacrylate) for Intranasal Drug Delivery: A Preliminary In Vivo Study.

Authors:  Inbar Schlachet; Hen Moshe Halamish; Alejandro Sosnik
Journal:  Molecules       Date:  2020-09-30       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.